250 results on '"Mogensen, Ulrik M."'
Search Results
2. Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial
3. The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trial
4. Association between Type D personality and outcomes in patients with non-ischemic heart failure
5. Self-reported health status and the associated risk of mortality in heart failure: The DANISH trial
6. Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women
7. Possible early detection of coronary artery calcium progression in type 1 diabetes: A case-control study of normoalbuminuric type 1 diabetes patients and matched controls
8. Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure
9. Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits
10. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status
11. Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study
12. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure
13. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial
14. Direct and Indirect Costs of Heart Failure Respective of Diabetes Status - a Nationwide Study
15. Direct and indirect costs of heart failure in relation to diabetes status - A nationwide study
16. Cause-specific death and risk factors of 1-year mortality after implantable cardioverter-defibrillator implantation:a nationwide study
17. Glycated haemoglobin levels among 3295 hospitalized COVID-19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all-cause mortality
18. Self-assessed health status and associated mortality in endocarditis:secondary findings from the POET trial
19. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation
20. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
21. Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study
22. Glycated haemoglobin levels among 3295 hospitalized COVID‐19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all‐cause mortality
23. Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer
24. Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer
25. Room for improvement:initiation of lipid-lowering treatment and achievement of lipid target levels—a Danish registry-based study
26. Serum potassium in the PARADIGM-HF trial
27. Early diastolic strain rate in relation to systolic and diastolic function and prognosis in acute myocardial infarction: a two-dimensional speckle-tracking study
28. Self-reported health status and the associated risk of mortality in heart failure:The DANISH trial
29. Quality of life and the associated risk of all-cause mortality in nonischemic heart failure
30. Long-Term Prognostic Importance of Diabetes After a Myocardial Infarction Depends on Left Ventricular Systolic Function
31. Cause-specific death and risk factors of 1-year mortality after implantable cardioverter-defibrillator implantation: a nationwide study
32. Quality of life and the associated risk of all-cause mortality in nonischemic heart failure
33. Room for improvement: initiation of lipid-lowering treatment and achievement of lipid target levels—a Danish registry-based study
34. Supplementary_tables_R2_CLEAN – Supplemental material for Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background population
35. Heart failure with reduced ejection fraction:comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas
36. Association between Type D personality and outcomes in patients with non-ischemic heart failure
37. The economic burden of heart failure in Denmark from 1998 to 2016
38. Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathy
39. Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background population
40. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis
41. The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial
42. Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus:A nationwide cohort study
43. Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF
44. Employment status at time of first hospitalization for heart failure is associated with death and rehospitalization for heart failure
45. Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure: a nationwide cohort study
46. Effect of sacubitril/valsartan on recurrent events in the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)
47. Evidence based therapy and its association with workforce detachment following first hospitalization for heart failure
48. The economic burden of heart failure in Denmark from 1998 to 2016
49. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis
50. The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.